Ziyuglycoside II( —— )

Catalog No. M18467 CAS No. 35286-59-0

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Ziyuglycoside II
Note

Research use only, not for human use.
Brief Description

Ziyuglycoside II has anticancer, and antitumor properties against gastric cancer and breast cancer cells, by cell cycle arrest and cell apoptosis.
Description

Ziyuglycoside II has anti-inflammation and antioxidation properties. Ziyuglycoside II has antibiosis, and homeostasis properties. Ziyuglycoside II has anticancer, and antitumor properties against gastric cancer and breast cancer cells, by cell cycle arrest and cell apoptosis.
In Vitro

Cell Viability Assay Cell Line:MDA-MB-435 cells Concentration:10, 20, 30, 40, 50, 60 μM Incubation Time:24 hours and 48 hours Result:The IC50 at 24 h and 48 h was 5.92 μM and 4.74 μM, respectively. Cell Cycle Analysis Cell Line:MDA-MB-435 cells Concentration:5, 10, 25 μM Incubation Time:24 hours Result:Induced G0/G1 and S phase arrest. Apoptosis Analysis Cell Line:MDA-MB-435 cells Concentration:5, 10, 25 μM Incubation Time:24 hours Result:The apoptotic rate was significantly increased in comparison to that of the control.Western Blot Analysis Cell Line:MDA-MB-435 cells Concentration:5, 10, 25 μM Incubation Time:24 hours Result:Treatment resulted in increased expressions of both p53 and p21.
In Vivo

——
Synonyms

——
Pathway

Neuroscience
Target

GluR
Recptor

Antioxidant
Research Area

Cancer|Inflammation/Immunology
Indication

——

CAS Number

35286-59-0
Formula Weight

604.82
Molecular Formula

C35H56O8
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 50 mg/mL (82.67 mM)
SMILES

CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1(C)O)C)C(=O)O
Chemical Name

——